Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Heart Diseases × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 43 Neoplasms 34 Colorectal Neoplasms 23 Lung Neoplasms 22 Uterine Cervical Neoplasms 13 Prostatic Neoplasms 13 Motor Activity 12 Colonic Neoplasms 10 Rectal Neoplasms 8 Pancreatic Neoplasms 8 Lymphoma 8 Carcinoma, Non-Small-Cell Lung 8 Anxiety Disorders 8 Obesity 7 Hematologic Neoplasms 7 Depression 7 Vulvar Neoplasms 6 Melanoma 6 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Breast Carcinoma In Situ 6 Urinary Bladder Neoplasms 5 Pain 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Hematopoietic and Lymphoid System Neoplasm 4 Fatigue 4 Carcinoma, Ovarian Epithelial 4 Vaginal Neoplasms 3

Interventions

Nutrition Assessment 2 liposomal doxorubicin 1 Vitamin E 1 Tomography, X-Ray Computed 1 Tomography, Emission-Computed 1 Positron-Emission Tomography 1 Methods 1 Magnetic Resonance Imaging 1 Educational Status 1 Case Management 1 Breathing Exercises 1 Atorvastatin 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03750110 2022-05-19

YESS

University of Nottingham

Phase NA Completed

Heart Diseases, Lung Neoplasms, Respiration Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡